search button

Androgens enhance the ability of intratumoral macrophages to promote breast cancer progression

  • Authors:
    • Mio Yamaguchi
    • Kiyoshi Takagi
    • Masayasu Sato
    • Ai Sato
    • Yasuhiro Miki
    • Yoshiaki Onodera
    • Minoru Miyashita
    • Hironobu Sasano
    • Takashi Suzuki

  • View Affiliations

  • Published online on: July 12, 2021     https://doi.org/10.3892/or.2021.8139
  • Article Number: 188
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Androgens are produced locally in breast carcinoma tissues by androgen‑producing enzymes such as 5α‑reductase type 1 (5αRed1) and affect not only breast cancer cells but the tumor microenvironment as well. Tumor‑associated macrophages (TAMs) are primary components of the tumor microenvironment and contribute to tumor progression. Although previous studies suggest that androgen/androgen receptor (AR) signaling in macrophages has important roles in human diseases, androgen action on TAMs has remained largely unknown. We immunolocalized macrophage marker CD163 as well as AR and 5αRed1 in 116 breast carcinomas and correlated them with clinicopathological parameters and clinical outcomes. Moreover, we examined the roles of androgens on macrophages in breast cancer progression using cell lines 4T1 (mouse breast cancer) and RAW264.7 (macrophage) in a tumor‑bearing female BALB/c mouse model. Double immunohistochemistry revealed that AR was sporadically expressed in the macrophages in breast carcinoma tissues. Macrophage infiltration was significantly correlated with an aggressive phenotype of breast carcinomas and worse prognosis, especially in the 5αRed1‑positive group. In a sphere‑forming assay using 4T1 and RAW‑AR cells, which stably express AR, the sphere size was significantly increased due to androgens when 4T1 cells were cocultured with RAW‑AR cells. Furthermore, in vivo experiments revealed that tumor growth and Ki67, a cell proliferation marker, were increased when androgens were stably produced in breast cancer cells and AR was expressed in macrophages. In conclusion, AR is expressed in intratumoral macrophages and is associated with an aggressive phenotype of breast carcinomas, especially when breast cancer cells actively produce androgens. Thus, androgens may enhance the ability of macrophages to promote breast cancer progression.
View Figures
View References

Related Articles

Journal Cover

September-2021
Volume 46 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.8
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.5
  • CiteScore Rank: Q1: #74/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.719
  • SCImago Journal Rank (SJR): 0.864
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Yamaguchi M, Takagi K, Sato M, Sato A, Miki Y, Onodera Y, Miyashita M, Sasano H and Suzuki T: Androgens enhance the ability of intratumoral macrophages to promote breast cancer progression. Oncol Rep 46: 188, 2021.
APA
Yamaguchi, M., Takagi, K., Sato, M., Sato, A., Miki, Y., Onodera, Y. ... Suzuki, T. (2021). Androgens enhance the ability of intratumoral macrophages to promote breast cancer progression. Oncology Reports, 46, 188. https://doi.org/10.3892/or.2021.8139
MLA
Yamaguchi, M., Takagi, K., Sato, M., Sato, A., Miki, Y., Onodera, Y., Miyashita, M., Sasano, H., Suzuki, T."Androgens enhance the ability of intratumoral macrophages to promote breast cancer progression". Oncology Reports 46.3 (2021): 188.
Chicago
Yamaguchi, M., Takagi, K., Sato, M., Sato, A., Miki, Y., Onodera, Y., Miyashita, M., Sasano, H., Suzuki, T."Androgens enhance the ability of intratumoral macrophages to promote breast cancer progression". Oncology Reports 46, no. 3 (2021): 188. https://doi.org/10.3892/or.2021.8139